Flushing

 

What is flushing?

Flushing is a temporary redness of the face and neck. It may also be accompanied by a warm feeling.

What causes flushing?

Flushing is caused by a dilation, or opening, of the blood vessels in the face. This brings more blood to the surface of the skin. The body uses this mechanism to “let off” heat because the blood is warm and the extra heat is released into the cooler, outside environment. Alcohol and drugs, including some chemotherapy drugs, cause flushing. Menopause, some hormonal treatments such as tamoxifen, a class of drugs called aromatase inhibitors (Aromasin® [exemestane], Femara® [letrozole] , and Arimidex® [anastrozole]), and LHRH-A drugs frequently used to treat prostate cancer also can cause flushing and sweating.

What is the treatment for flushing?

The treatment for flushing depends upon the cause. Be sure to tell your doctor of any side effects that cause you concern. Medications in the antidepressant class, such as Effexor-XR® (venlafaxine) and the SSRI’s (Prozac® (fluoxetine), etc.), can help alleviate the symptom if it is hormone related as discussed above.

This content was last reviewed August 15, 2010 by Dr. Reshma L. Mahtani.
Latest Cancer News
REFILE: Komen charity under microscope for funding, science

February 8, 2012 — NEW YORK (Reuters) - The Susan G. Komen for the Cure charity defines its mission as finding a cure for breast cancer. In recent years, however, it has cut by nearly half the proportion of fund-raising dollars it spends on grants to scientists working to understand the causes and develop effective new treatments for the disease.

US FDA panel votes against wider use of Amgen drug

February 8, 2012 — WASHINGTON (Reuters) - An advisory panel on Wednesday recommended that U.S. health regulators reject the use of Amgen Inc's drug Xgeva to delay the spread of prostate cancer to the bone, dimming the chance of a wider use for one of the company's key growth drivers.

US consumers want tougher probe of engineered salmon

February 8, 2012 — WASHINGTON (Reuters) - Three U.S. consumer groups petitioned the Food and Drug Administration on Tuesday to subject a new genetically engineered salmon to a more rigorous review process than is now in place before the fish can be approved as safe to eat.

Select news items provided by Reuters Health